Latest Sustainability News

Coast Entertainment Holdings reports a robust FY25 with double-digit growth in visitation and revenue, driven by new attractions and strong promotional campaigns. Despite weather disruptions and cautious international recovery, the company starts FY26 on a high note.

Green Critical Minerals has commissioned its first VHD Graphite production module and secured $7 million to drive commercialisation, while its McIntosh Project delivers robust economic metrics.

BTC Health has secured a $0.5 million order for its life-saving ECMO equipment from the Women's and Children's Hospital in Adelaide, marking a significant expansion of its specialised medical device network alongside Melbourne's Royal Children's Hospital.

Horizon Oil has reached financial close on a US$21.5 million amended senior debt facility with Macquarie Bank, paving the way for its strategic acquisition in Thailand. The facility enhances funding capacity for existing assets and supports future development plans.

Qoria Limited reported a robust 25% year-on-year growth in annual recurring revenue, hitting $145 million, alongside a 670% jump in EBITDA and a positive free cash flow outlook for FY2026. The company’s expanding global footprint and strategic partnerships underpin its strong momentum.

Perpetual Limited reported a 2.5% increase in assets under management to A$226.8 billion for Q4 FY25, driven by strong market performance and inflows. The company reaffirmed its expense guidance and continues to pursue the sale of its Wealth Management business.

Metro Mining Limited has reported record Q2 shipments and site EBITDA margins, driven by a fully operational expansion and a robust bauxite market. Operational challenges from a tropical storm have been resolved, and exploration activities are accelerating.

Carnarvon Energy is set to become Strike Energy’s largest shareholder through a strategic A$88 million equity placement, underpinning key project developments in Western Australia’s Perth Basin. Strike also launches a Share Purchase Plan to raise additional funds, aiming to accelerate production milestones by 2026.

Microba Life Sciences reports strong Q4 FY25 growth driven by record microbiome test sales and clinician adoption in Australia and the UK, while advancing its therapeutics pipeline and targeting regional break-even in FY26.

Microba Life Sciences reports record Q4 FY25 microbiome test sales in Australia and the UK, underpinned by landmark clinical studies and a $14.5 million capital raise. The company is transitioning away from legacy products to focus on high-value diagnostics, positioning for sustained growth in FY26.

Praemium Limited reports a 2.2% increase in funds under administration for Q4 FY25, driven by strong gains in Spectrum and SMA platforms, alongside operational upgrades including AI-driven initiatives. However, OneVue platform experiences a significant decline.

Qualitas Limited has announced the early release of over 30 million shares from voluntary escrow, significantly increasing the free float ahead of schedule and potentially enhancing market liquidity.